Company
Trimi Health
Trimi Health publishes compounded semaglutide and compounded tirzepatide, from $175 to $235 a month.
- 2 programs
- 2 molecules
- 2 readings
Read from trytrimi.com on September 13, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to Trimi Health
This is a paid link. If you enroll through it, Treatment Registry may earn a commission. It does not change what we record, and it does not change the price you pay.
What it costs
first month, everything required included · Monthly
first month, everything required included · Monthly
Terms
| Pharmacy | VialsRx and GreenwichRx |
|---|---|
| Membership | Not disclosed |
| Consultation fee | Not disclosed |
| States | All 50 states |
Those the company does not disclose were checked on September 13, 2026.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 13, 2026
- 1. Trimi publishes both halves of every tier itself — the charge and the monthly equivalent — under the heading “Clear prices. The full amount, upfront.”, and states the arithmetic it used: “The monthly equivalent is the term price divided by its months.” Nothing here is multiplied out. Its annual tiers carry a 12-month commitment.
- 2. Trimi's clinical partner is the Arora Health network, led by Sean Arora, MD, and its medication is compounded by VialsRx (Texas State Board pharmacy license #35264) and GreenwichRx. Renlo Health names the same provider group and the same pharmacy, and Idgie Health names the same pharmacy. Three companies in this register share that clinical layer, and a reader treating them as three independent options is not getting three.
Before you act
Cite this
Treatment Registry. (2026). Trimi Health: recorded programs and prices. Last verified September 13, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/trimi